Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Cacabelos, R.
1996.
Diagnosis of Alzheimer's disease: defining genetic profiles (genotype vs phenotype).
Acta Neurologica Scandinavica,
Vol. 94,
Issue. S165,
p.
72.
Cohen-Mansfield, Jiska
Gruber-Baldini, Ann L.
Culpepper, William J.
and
Werner, Perla
1996.
Longitudinal Changes in Cognitive Functioning in Adult Day Care Participants.
Journal of Geriatric Psychiatry and Neurology,
Vol. 9,
Issue. 1,
p.
30.
Small, Brent J.
Viitanen, Matti
Winblad, Bengt
and
Bäckman, Lars
1997.
Cognitive changes in very old persons with dementia: The influence of demographic, psychometric, and biological variables.
Journal of Clinical and Experimental Neuropsychology,
Vol. 19,
Issue. 2,
p.
245.
Rajaram, Suparna
1997.
Basal forebrain amnesia.
Neurocase,
Vol. 3,
Issue. 6,
p.
405.
Neri, M.
Rubichi, S.
DeVreese, L.P.
Roth, M.
and
Cipolli, C.
1998.
Validation of the Full and Short Forms of the CAMDEX Interview for Diagnosing Dementia: Evidence from a One-Year Follow-Up Study.
Dementia and Geriatric Cognitive Disorders,
Vol. 9,
Issue. 6,
p.
339.
Rogers, S.L
Doody, R.S
Pratt, R.D
and
Ieni, J.R
2000.
Long-term efficacy and safety of donepezil in the treatment of Alzheimer’s disease: final analysis of a US multicentre open-label study.
European Neuropsychopharmacology,
Vol. 10,
Issue. 3,
p.
195.
Neri, M.
Roth, M.
Rubichi, S.
DeVreese, L. P.
Bolzani, R.
and
Cipolli, C.
2001.
The validity of informant report for grading the severity of Alzheimer’s Dementia.
Aging Clinical and Experimental Research,
Vol. 13,
Issue. 1,
p.
22.
Winblad, B.
Engedal, K.
Soininen, H.
Verhey, F.
Waldemar, G.
Wimo, A.
Wetterholm, A.-L.
Zhang, R.
Haglund, A.
and
Subbiah, P.
2001.
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
Neurology,
Vol. 57,
Issue. 3,
p.
489.
Tariot, Pierre N.
Cummings, Jeffrey L.
Katz, Ira R.
Mintzer, Jacobo
Perdomo, Carlos A.
Schwam, Elias M.
and
Whalen, Edward
2001.
A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting.
Journal of the American Geriatrics Society,
Vol. 49,
Issue. 12,
p.
1590.
Waldemar, Gunhild
2001.
Donepezil in the treatment of patients with Alzheimer’s disease.
Expert Review of Neurotherapeutics,
Vol. 1,
Issue. 1,
p.
11.
Tariot, Pierre N.
Cummings, Jeffrey L.
Katz, Ira R.
Mintzer, Jacobo
Perdomo, Carlos A.
Schwam, Elias M.
and
Whalen, Edward
2001.
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting.
Journal of the American Geriatrics Society,
Vol. 49,
Issue. 12,
p.
1590.
Ashford, J. Wesson
and
Schmitt, Frederick A.
2001.
Modeling the time-course of Alzheimer dementia.
Current Psychiatry Reports,
Vol. 3,
Issue. 1,
p.
20.
Paul, Robert H.
Cohen, Ronald A.
Moser, David J.
Ott, Brian R.
Sethi, Manish
Sweet, Lawrence
Browndyke, Jeff
Malloy, Paul
and
Garrett, Kelly
2003.
Clinical Correlates of Cognitive Decline in Vascular Dementia.
Cognitive and Behavioral Neurology,
Vol. 16,
Issue. 1,
p.
40.
Froelich, L.
Gertz, H.-J.
Heun, R.
Heuser, I.
Jendroska, K.
Kornhuber, J.
Kurz, A.
Mueller-Thomsen, T.
Ries, F.
Waechtler, C.
Metz, M.
and
Goebel, C.
2004.
Donepezil for Alzheimer’s Disease in Clinical Practice – The DONALD Study.
Dementia and Geriatric Cognitive Disorders,
Vol. 18,
Issue. 1,
p.
37.
Rawls, Nathan W.
2005.
Donepezil in More Advanced Alzheimer's Disease.
The Consultant Pharmacist,
Vol. 20,
Issue. 7,
p.
592.
Kirk, Andrew
2007.
Target Symptoms and Outcome Measures: Cognition.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 34,
Issue. S1,
p.
S42.
Guerrero‐Berroa, Elizabeth
Luo, Xiaodong
Schmeidler, James
Rapp, Michael A.
Dahlman, Karen
Grossman, Hillel T.
Haroutunian, Vahram
and
Beeri, Michal Schnaider
2009.
The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.
International Journal of Geriatric Psychiatry,
Vol. 24,
Issue. 12,
p.
1429.
Jelic, Vesna
and
Darreh-Shori, Taher
2010.
Donepezil: A Review of Pharmacological Characteristics and Role in the Management of Alzheimer Disease.
Clinical Medicine Insights: Therapeutics,
Vol. 2,
Issue. ,
Lopez, Oscar L.
Schwam, Elias
Cummings, Jeffrey
Gauthier, Serge
Jones, Roy
Wilkinson, David
Waldemar, Gunhild
Zhang, Richard
and
Schindler, Rachel
2010.
Predicting cognitive decline in Alzheimer's disease: An integrated analysis.
Alzheimer's & Dementia,
Vol. 6,
Issue. 6,
p.
431.
Babiloni, Claudio
Del Percio, Claudio
Bordet, Regis
Bourriez, Jean-Luis
Bentivoglio, Marina
Payoux, Pierre
Derambure, Philippe
Dix, Sophie
Infarinato, Francesco
Lizio, Roberta
Triggiani, Antonio Ivano
Richardson, Jill C.
and
Rossini, Paolo M.
2013.
Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer’s disease patients.
Clinical Neurophysiology,
Vol. 124,
Issue. 5,
p.
837.